Generalized seizures, including myoclonus, starting 2 to 6 months after the earliest clinical manifestations, characterize infantile onset NCL (infantile CLN1 and CLN10 diseases). This evidence concerns the gene PPT1 and neuronal ceroid lipofuscinosis.